MOTILITY DISORDERS GASTROINTESTINAL & HEPATOLOGY SOLUTIONS
Functional disorders and associated symptoms are among the most diagnosed in outpatient clinics. Over nine million patients experience symptoms of a swallowing disorder annually.1 Symptoms vary from dysphagia to fecal incontinence.2 Over 30 million patients in the U.S. suffer from symptoms of fecal incontinence, gastroparesis, or slow transit constipation.1-4
Esophageal disease patients can have similar symptoms, but their diseases may be different. This means tests aren't always conclusive and treatment isn't always effective. Up to 50% of endoscopies for predominant esophageal symptoms are negative.6-8
The EndoFlip™ impedance planimetry system:
Support early detection of gastrointestinal diseases and functional disorders with a complete portfolio of motility testing products. Our esophageal manometry and anorectal manometry motility testing systems enable you to do full evaluations of GI tract motor function to understand the root cause of GI functional disorders.11-13
The ManoScan™ high resolution manometry system allows for enhanced sensitivity that provides useful information to support diagnosis of conditions like dysphagia, achalasia, and hiatal hernia14-16
The sensor-based capsule allows for GI functional assessment with a single test. SmartPill™ provides valuable diagnostic information, including gastric emptying time, colonic transit time, whole gut transit time, and pressure patterns from the antrum and duodenum.
The SmartPill™ motility testing system:
Bhattacharyya N. The prevalence of dysphagia among adults in the United States. Otolaryngol Head Neck Surg. 2014;151(5):765-9.
Whitehead W, Borrud L, Goode P, Meikle S, Mueller E, Tuteja A, et al. Fecal Incontinence in U.S. Adults: Epidemiology and Risk Factors. Gastroenterology. 2009 August;137(2):512–517.e2. doi:10.1053/j.gastro.2009.04.054.
Halder SL, Locke GR, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007 Sep;133(3):799-807. Epub 2007 Jun 2
Cassell Benjamin, Sayuk Gregory My Approach to Endoscopy-Negative Dysphagia Gastroenterology March 31 2015
Lambert R. Digestive endoscopy: Relevance of negative findings. Italian journal of gastroenterology and hepatology 31(8):761-72
ASGE Standards of Practice Committee, Muthusamy VR, Lightdale JR, Acosta RD et al. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81(6):1305-10.
Ronkainen et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005; 129: 1825-1831.
Medtronic. Endoflip™ impedance planimetry system instructions for use (IFU). DD-41 Rev E. 2016.
Medtronic. Flip™ topography module instructions for use (IFU). DD-948 Rev A. 2017.
Kahrilas PJ. Esophageal motor disorders in terms of high-resolution esophageal pressure topography: what has changed? Am J Gastroenterol. 2010;105:981-7.
Conklin J. Color Atlas of High Resolution Manometry. Springer Publishing. 2009. Page 71.
Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109:1141-57.
Bansal A, et al. Has high-resolution manometry changed the approach to esophageal motility disorders? Curr Opin Gastroenterol. 2010;26;344-351.
Pandolfino JE, Kahrilas PJ. AGA medical position statement. Clinical use of esophageal manometry. Gastroenterology. 2005;128:207-208.
Raeo, et al. Evaluation of gastroinestinal transit in clinical practice: Position pager of the American and European Neurogastroenterology and Motility Societies. Neurogastroentrerol Motil. 2011;23(1):8-23.
Rao "Diagnostic utility of WMC..." J Clin Gastroenterol 2010
Image does not represent all components of the system